VECTRA Trademark

Trademark Overview

On Thursday, October 15, 2020, a trademark application was filed for VECTRA with the United States Patent and Trademark Office. The USPTO has given the VECTRA trademark a serial number of 90978931. The federal status of this trademark filing is REGISTERED as of Tuesday, March 7, 2023. This trademark is owned by Crescendo Bioscience, Inc.GS. The VECTRA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical diagnostic testing to determine the risk of cardiovascular disease in individuals with inflammatory diseases for diagnostic and treatment purposes
vectra

General Information

Serial Number90978931
Word MarkVECTRA
Filing DateThursday, October 15, 2020
Status700 - REGISTERED
Status DateTuesday, March 7, 2023
Registration Number6997903
Registration DateTuesday, March 7, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements

Goods and ServicesMedical diagnostic testing to determine the risk of cardiovascular disease in individuals with inflammatory diseases for diagnostic and treatment purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 3, 2020
Primary Code044
First Use Anywhere DateSaturday, October 30, 2010
First Use In Commerce DateSaturday, October 30, 2010

Trademark Owner History

Party NameLABORATORY CORPORATION OF AMERICA HOLDIN
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBURLINGTON, NC 27215
Party NameLABORATORY CORPORATION OF AMERICA HOLDIN
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBURLINGTON, NC 27215
Party NameLABORATORY CORPORATION OF AMERICA HOLDINGS
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBURLINGTON, NC 27215
Party NameCrescendo Bioscience, Inc.GS
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, March 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 7, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, February 2, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 1, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, January 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 6, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 7, 2022USE AMENDMENT FILED
Friday, January 6, 2023SOU EXTENSION 1 GRANTED
Wednesday, December 7, 2022SOU EXTENSION 1 FILED
Thursday, January 5, 2023DIVISIONAL PROCESSING COMPLETE
Wednesday, December 7, 2022DIVISIONAL REQUEST RECEIVED
Thursday, January 5, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 7, 2022TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 7, 2022TEAS EXTENSION RECEIVED
Wednesday, December 7, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, June 7, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 3, 2022ASSIGNED TO EXAMINER
Wednesday, October 20, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 12, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 12, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 12, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 10, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 10, 2021NON-FINAL ACTION E-MAILED
Saturday, April 10, 2021NON-FINAL ACTION WRITTEN
Tuesday, March 16, 2021ASSIGNED TO EXAMINER
Thursday, December 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 19, 2020NEW APPLICATION ENTERED

Related Keywords

vectra diagnostic inflammatory diseases purposes individuals treatment cardiovascular testing determine risk